Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-22.90%
↓ 179% below average
Average (27q)
-8.21%
Historical baseline
Range
High:38.60%
Low:-67.50%
Volatility
-1292.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -22.90% |
| Q2 2025 | -15.93% |
| Q1 2025 | 0.00% |
| Q4 2024 | -20.21% |
| Q3 2024 | -16.05% |
| Q2 2024 | -15.71% |
| Q1 2024 | 38.60% |
| Q4 2023 | -15.15% |
| Q3 2023 | -7.61% |
| Q2 2023 | -48.39% |
| Q1 2023 | 1.59% |
| Q4 2022 | 27.59% |
| Q3 2022 | -7.41% |
| Q2 2022 | -5.19% |
| Q1 2022 | -8.45% |
| Q4 2021 | 1.39% |
| Q3 2021 | -20.00% |
| Q2 2021 | -13.21% |
| Q1 2021 | -1.92% |
| Q4 2020 | -23.81% |
| Q3 2020 | 8.70% |
| Q2 2020 | 31.34% |
| Q1 2020 | -67.50% |
| Q4 2019 | -14.29% |
| Q3 2019 | -25.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 9.68% |
| Q4 2018 | 0.00% |